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Chlorpromazine reduces UV-induced squamous cell carcinogenesis in
hairless mice and enhances UV-induced DNA damage in cultured cells
M.J. Peak, M. Pfaff & C. Peraino
Biological, Environmental, and Medical Research Division, Argonne National Laboratory, Argonne, IL 60439-4833, USA.
Summary Administration of the photoactivable compound chlorpromazine (CPZ) to SKH-1 hairless mice
via their drinking water (CPZ, 0.01%) significantly reduced the rates of accumulation and yields of squamous
cell carcinomas induced by long-term repeated exposures of these animals to solar UV radiation. This
protective effect of CPZ was partially reversed in mice given a single injection of ethyl nitrosourea at birth. In
in vitro studies, the presence of CPZ (0.2 mM) in mammalian cell cultures enhanced the yield of DNA single-
strand breaks induced in the cells by exposure to monochromatic UVA radiation at 334 nm. Collectively, the
results suggest that CPZ may exert antineoplastic effects against UV-induced skin tumours by the induction
of DNA damage.
Chlorpromazine CPZ, 2-chloro-N,N-dimethyl-10-phenothia-
zine-10-propanamine), a commonly prescribed sedative,
tranquiliser and anti-emetic, is also a highly photoactive com-
pound (Kochevar, 1987). Photoactivation of CPZ produces
oxidising CPZ radicals (including promazyl, peroxy and
hydroxyl radicals) that are known to have cytotoxic effects
on biological systems (Ciulla et al., 1986; Decuyper et al.,
1986; Fujita et al., 1981). Therefore, the exposure of indivi-
duals ingesting CPZ to high fluences of ultraviolet A (UVA)
radiation (radiation between 320nm and visible light, such
as that found in solar UV or tanning booth radiation)
should increase the body burden of oxidising radicals,
especially in the epidermal tissues, into which the longer
wavelengths of UVA readily penetrate (Bruls et al., 1984).
This increment in tissue free radicals should enhance tumori-
genesis, in keeping with the postulated role of free radicals
as promoters of neoplasia (Gilbert, 1972; Greenstock &
Ruddock, 1978; Greenstock & Wiebe, 1978; Pryor, 1978;
Troll, 1978; Ames, 1983; Kinsella et al., 1983; Marx, 1983;
Cerutti, 1985; Jones, 1985). Therefore, it might be antici-
pated that the ingestion of phenothiazines that are suscept-
ible to photoactivation would enhance tumorigenic risk.
Contrary to such expectations, however, clinical observations
(in cancer patients given CPZ as a nausea suppressant during
chemotherapy), epidemiological studies of mental hospital
inmates receiving phenothiazine therapy and experimental
evidence from studies with rodents indicate that pheno-
thiazines such as CPZ may have antineoplastic activity
(Jones, 1985; Darkin et al., 1984).
Because none of the foregoing studies of phenothiazine
antineoplasia addressed the issue of phenazine photo-
activation and the biological effects of the resultant oxidising
free radicals, we were prompted to perform an experiment to
test possible enhanced or diminished neoplastic effects of
dietary CPZ in groups of rodents exposed to carcinogenic
solar UV radiations. The preliminary data have been
reported previously (Peak et al., 1987b). Here we describe
the kinetics of tumour appearance. We also assessed DNA
breakage in cultured mammalian cells exposed to CPZ and
UVA to determine whether CPZ can cause photosensitised
DNA cleavage in intact mammalian cells, as well as in
isolated DNA (Decuyper et al., 1986; Fujita et al., 1981) or
in a DNA nucleotide residue (Ciulla et al., 1986).
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Materials and methods
Animals
Male and female hairless SKH-1 mice (5-10 weeks old, bred
at Argonne National Laboratory) were assigned to eight
treatment groups (equal numbers of males and females per
group; number per group shown in parentheses) as follows:
untreated control (50); CPZ in drinking water, starting
within 3 days of weaning (100); sunlamp exposure regime,
starting 3 days after weaning (100); CPZ plus sunlamp
exposure (50); injected ENU (50); ENU plus CPZ (50); ENU
plus sunlamp exposure (41); ENU plus CPZ plus sunlamp
exposure (43). These groups were termed control, CPZ, UV,
UV + CPZ, ENU, CPZ + ENU, UV + ENU and
UV + CPZ + ENU, respectively. CPZ was given during the
entire 16 weeks of UV treatments.
Animals received Wayne Lab Blox and water ad libitum
and were housed one per cage (male) or three to five per
cage (females) in rooms illuminated with Westinghouse
F40G0 yellow lamps on a 12h light, 12h dark diurnal
schedule.
UV exposures
Animals were irradiated from above by banks of
Westinghouse FS40 sunlamps on Mondays, Wednesdays and
Fridays, at a total fluence per exposure of 1,500Jm-2 and a
fluence rate of 3 Wm-2 for a total of 16 weeks, starting
shortly after they were weaned. Dosimetry was performed
with a calibrated Yellow Springs Instruments 65A radio-
meter and a calibrated Robertson-Berger erythema meter.
Human P3 teratocarcinoma cells isolated as described
previously (Huberman et al., 1984) were grown and
irradiated with monochromatic 334nm radiation (present in
the solar UV spectrum) exactly as described (Jones et al.,
1987), in the presence or absence of CPZ (200pM).
Chemical treatments
Fresh CPZ (lot 44F-0667 from Sigma) was prepared three
times weekly and dispensed from brown glass drinking
bottles in deionised water. Animals were given 0.01% CPZ
in their water for the first 10 weeks of the experiment, then
the concentration was increased to 0.1%. A preliminary
study showed that with this protocol the drug is subtoxic.
ENU was administered by intraperitoneal injection within
24h of birth at a dose of 100Mg per g body weight. To
assess DNA damage in cultured mammalian cells, CPZ was
used at concentration of 0.007% and administered as des-
cribed (Jones et al., 1987).
Tumours and pathology
All visible cutaneous lesions (>1 mm diameter) wereCHLOROPROMAZINE AND UV 221
recorded weekly, and only those that persisted were scored.
At the end of the experiment, animals were preserved in
10% formalin. Fourteen characteristic tumours were
sectioned and stained by routine histochemical methods, plus
the two apparent tumours that appeared in the ENU + CPZ
group.
Alkaline elution assay
DNA single-strand breaks (SSB) were determined by the
alkaline filter elution technique (Cunningham et al., 1987;
Kohn et al., 1981). The numbers of breaks induced in the
DNA of human cells in culture by monochromatic 334nm
radiation in the presence and absence of CPZ (200pM) were
calculated from the slopes of the elution profiles as described
(Kohn et al., 1981) with an X-irradiated (3Gy) standard;
3 Gy of X-rays have been shown to induce 8.1 SSB per 1010
daltons in human cells (Hill et al., 1988).
Results
Skin tumour induction
The rates of appearance and yields of tumours are shown in
Figure 1. No tumours developed in mice that did not receive
UV treatments. (Two apparent tumours in the ENU + CPZ
groups reported earlier (Peak et al., 1987b) were
subsequently identified as necrotic sebaceous cysts.) All the
other tumours sectioned were diagnosed as squamous cell
carcinomas at the end of the experiment.
In the UV-treated groups, tumours first appeared between
the 9th and 17th weeks and were present in all mice by the
40th week. Comparison of tumour yields in mice receiving
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Figure 1 Yields and incidence rates of tumours in four groups of
mice. In (a) the total tumour yield is per mouse normalised
to unity against the maximum value of the UV + ENU group.
The groups that showed no tumours are omitted. O UV;
* UV + ENU; l UV + ENU + CPZ; I UV + CPZ;
abbreviations to the groups are defined in the Materials and
methods section.
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Figure 2 Effect of 200pM CPZ on the induction of SSB in
human P3 cells by monochromatic 334nm UV radiation. Cells
were washed and resuspended in PBS-A and irradiated at 0.5°C
with and without CPZ added to their medium (PBS-A) while
they were kept in suspension with gentle stirring. They were
exposed to two fluences of UV and were immediately analysed
for molecular weight by alkaline elution procedures.
UV alone with those receiving UV + CPZ shows that the
CPZ treatment diminished tumour yields by approximately
80% (Figure la) and caused a reduction of approximately
four-fold in the kinetics of tumour incidence after week 15
(Figure lb). Treatment with ENU at birth enhanced tumour
yields similarly in mice subsequently exposed to UV or
UV + CPZ (Figure la) and virtually eliminated the CPZ-
mediated reduction in UV-induced tumour incidence kinetics
(Figure lb).
DNA damage
Figure 2 shows that the exposure of mammalian cells to
monochromatic radiation at 334 nm alone caused a
substantial SSB incidence, as was demonstrated previously
(Peak et al., 1987a). No SSB were induced by the CPZ in the
dark. The data in Figure 2 also demonstrate that the
presence of CPZ at 200gM during irradiation approximately
tripled the yields of SSB per unit fluence. The experiment
was repeated and gave essentially similar results. Therefore,
the presence of membranes and chemical barriers around the
DNA in the intact cells (as opposed to exposure of isolated
DNA (Ciulla et al., 1986; Decuyper et al., 1986; Fujita et al.,
1981)) did not protect the DNA from damage resulting from
the photoenergetic production of CPZ radicals.
Discussion
The current observation that CPZ ingestion markedly
inhibits solar UV-induced squamous cell carcinoma in hair-
less mice is in agreement with prior evidence for antineo-
plastic effects of phenothiazines in other systems (Darkin et
al., 1984; Jones, 1985). The possibility that CPZ is exerting
its protective effect here by screening the target cell from UV
exposure is unlikely in view of the partial elimination of the
antineoplastic activity of CPZ by the ENU treatment (which
has no intrinsic skin tumorigenic effect). Clearly, under the
latter conditions tumorigenic UV radiation reaches its target
despite the presence of CPZ.
As yet, it is unclear whether the antineoplastic effects of
CPZ are exerted by the parent compound or by UV-induced
photoproducts. However, the observations that (a) such
photoproducts cause DNA breakage in mammalian cells and
(b) UV penetration in skin is sufficient to photoactivate
ingested CPZ (Bruls et al., 1984) are compatible with a
causal role for photoactivation in CPZ antineoplasia.222 M.J. PEAK et al.
Further studies are required to verify this causality and to
determine whether the antineoplastic mechanism involves: (a)
direct cell killing; (b) enhancement of DNA repair processes,
possibly induced by DNA damage itself; (c) stimulation of
immunological defences against tumour cell propagation; or
(d) inhibition of the promotion phase of tumorigenesis by
such possible means as inhibition of protein kinaseC (Mori
et al., 1986), an enzyme involved in cell surface signal
transduction that is responsive to promoting stimuli
(Nishizuka, 1984).
We thank L. Pippin, DVM for performing the histopathology. This
investigation was supported by the US Department of Energy under
contract no. W-31-109-ENG-38.
References
AMES, B.N. (1983). Dietary carcinogens and anticarcinogens.
Science, 221, 1256.
BRULS, W.A.G., SLAPER, H., VAN DER LEUN, J.C. & BERRENS, L.
(1984). Transmission of human epidermis and stratum corneum
as a function of thickness in the ultraviolet and visible
wavelengths. Photochem. Photobiol., 40, 485.
CERUTTI, P.A. (1985). Prooxidant states and tumour promotion.
Science, 227, 375.
CIULLA, T., EPLING, G.A. & KOCHEVAR, I.E. (1986). Photoaddition
of chlorpromazine to guanosine-5'-monophosphate. Photochem.
Photobiol., 43, 607.
CUNNINGHAM, M.L., PEAK, J.G. & PEAK, M.J. (1987). Single-strand
DNA breaks in rodent,and human cells produced by superoxide
anion or its reduction products. Mutat. Res., 184, 217.
DARKIN, S., McQUILLAN, J. & RALPH, R.K. (1984).
Chlorpromazine: A potential anticancer agent. Biochem. Biophys.
Res. Commun., 125, 184.
DECUYPER, J., PIETTE, J., MERVILLE, M.-P. & VAN DE VORST, A.
(1986). Termini generated at the site of DNA breakage mediated
by photoexecuted promazines. Biochem. Pharmacol., 33, 1345.
FUJITA, H., HAYASHI, H. & SUZUKI, K. (1981). Spectrofluorometric
study on photochemical interaction between chlorpromazine and
nucleic acids. Photochem. Photobiol., 34, 101.
GILBERT, D.L. (1972). Oxygen and life. Anesthesiology, 37, 100.
GREENSTOCK, C.L. & RUDDOCK, G.W. (1978). Radiation activation
of carcinogenens and the role of -OH and O-. Photochem.
Photobiol., 28, 877.
GREENSTOCK, C.L. & WIEBE, R.H. (1978). Photosensitized
carcinogen degradation and the possible role of singlet oxygen in
carcinogenic activation. Photochem. Photobiol., 28, 863.
HILL, C.K., HOLLAND, J., CHANG-LIU, C.M., BUESS, E.M., PEAK,
J.G. & PEAK, M.J. (1988). Human epithelial teratocarcinoma cells
(P3): radiobiological characterization, DNA damage, and com-
parison with other rodent and human cell lines. Radiat. Res., 113,
278.
HUBERMAN, E., McKEOWN, C.K., JONES, C.A., HOFFMAN, D.R. &
MURAO, S. (1984). Induction of mutations at the hypoxanthine-
guanine phosphoribosyl transferase locus in human epithelial
teratoma cells. Mutat. Res., 130, 127.
JONES, G.R.N. (1985). Cancer therapy: phenothiazines in an
unexpected role. Tumori, 71, 563.
JONES, C.A., HUBERMAN, E., CUNNINGHAM, M.L. & PEAK, M.J.
(1987). Mutagenesis and cytotoxicity in human epithelial cells by
far- and near-ultraviolet radiations: action spectra. Radiat. Res.,
110, 244.
KINSELLA, A.R., GAINER, H.ST.C. & BUTLER, J. (1983).
Investigation of a possible role for superoxide anion production
in tumour promotion. Carcinogenesis, 4, 717.
KOCHEVAR, I.E. (1987). Mechanisms of drug photosensitization.
Photochem. Photobiol., 45, 891.
KOHN, K.W., EWIG, R.A.G., ERICKSON, L.G. & ZWELLING, L.A.
(1981). Measurement of strand breaks and cross-links by alkaline
elution. In DNA Repair 1. A Laboratory Manual of Research
Procedures, Friedberg, E.C. & Hanawalt, P.C. (eds) p. 379.
Marcel Dekker: New York.
MARX, J.L. (1983). Do tumour promoters affect DNA after all?
Science, 219, 158.
MORI, T., TAKAI, Y., MINAKUCHI, R., YU, B. & NISHIZUKA, R.
(1980). Inhibitory action of chlorpromazine, dibucaine, and other
phospholipid-interacting drugs on calcium-activated,
phospholipid-dependent protein kinase. J. Biol. Chem., 255, 8378.
NISHIZUKA, Y. (1984). The role of protein kinase C in cell surface
signal transduction and tumour promotion. Nature, 308, 693.
PEAK, M.J., PEAK, J.G. & CARNES, B.S. (1987a). Induction of direct
and indirect single-strand breaks in human cell DNA by far- and
near-ultraviolet radiations: action spectrum and mechanisms.
Photochem. Photobiol., 45, 381.
PEAK, M.J., PFAFF, M.M. & PERAINO, C.D. (1987b). Chlorpromazine
ingestion inhibits UV-induced skin carcinogenesis. Photochem.
Photobiol., 46, 1.
PRYOR, W.A. (1978). The formation of free radicals and the
consequences of their reaction in vivo. Photochem. Photobiol., 28,
787.
TROLL, W. (1981). Free oxygen radicals-modulators of carcinogens.
In Environmental Carcinogens and Mutagens, Sugimura, T.,
Kondo, S. & Takebe, H. (eds) p. 217. Alan R. Liss: New York.